Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mepaco, officially known as Middle East Pharmaceutical & Chemical Industries & Medical Appliances, is a leading Egyptian pharmaceutical company specializing in the development and manufacture of herbal medicines and generic pharmaceuticals. Established in 1985 as a subsidiary of the Arab Company for Drug Industries and Medical Appliances (ACDIMA), the company has carved a niche in the "Medifood" sector, focusing on high-quality plant-based therapeutic solutions. Mepaco operates a sophisticated manufacturing complex in Egypt that adheres to international Good Manufacturing Practices (GMP) and ISO standards. Their extensive product portfolio covers a wide range of therapeutic areas, including gastroenterology, hepatology, and respiratory health. In addition to its proprietary brands, Mepaco provides contract manufacturing and extraction services for regional and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mepaco.